Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May 1;3(5):705-707.
doi: 10.1001/jamaoncol.2016.5465.

Increase in Prostate Cancer Distant Metastases at Diagnosis in the United States

Jim C Hu  1 , Paul Nguyen  2 , Jialin Mao  3 , Joshua Halpern  1 , Jonathan Shoag  1 , Jason D Wright  4 , Art Sedrakyan  3
Affiliations

Increase in Prostate Cancer Distant Metastases at Diagnosis in the United States

Jim C Hu et al. JAMA Oncol. .

Erratum in

  • Error in Methods Section.
    [No authors listed] [No authors listed] JAMA Oncol. 2017 May 1;3(5):709. doi: 10.1001/jamaoncol.2017.0054. JAMA Oncol. 2017. PMID: 28152121 Free PMC article. No abstract available.

Abstract

This population-based study assesses the effect of the decline in prostate-specific antigen screening and incidence on prostate cancer presentation.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Hu reported being on the Speakers’ Bureau for Intuitive Surgical and Genomic Health. Dr Nguyen reported consulting for Ferring and Nanobiotix. No other disclosures were reported.

Figures

Figure.
Figure.. Standardized Incidence of Prostate Cancer Distant Metastasis at Diagnosis by Quarter Between 2004 and 2013 Among Men Aged 75 Years and Older and Younger Than 75 Years
Dashed vertical blue lines demonstrate the release of the 2008 and 2012 screening recommendations.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. National Cancer Institute Surveillance, Epidemiology, and End Results program. http://seer.cancer.gov/. Accessed April 26, 2016.
    1. Schröder FH, Hugosson J, Roobol MJ, et al. ; ERSPC Investigators . Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360(13):1320-1328. - PubMed
    1. Moyer VA; U.S. Preventive Services Task Force . Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157(2):120-134. - PubMed
    1. Shoag JE, Mittal S, Hu JC. Reevaluating PSA testing rates in the PLCO Trial. N Engl J Med. 2016;374(18):1795-1796. - PubMed
    1. Jemal A, Ma J, Siegel R, Fedewa S, Brawley O, Ward EM. Prostate cancer incidence rates 2 years after the US Preventive Services Task Force recommendations against screening [published online August 18, 2016]. JAMA Oncol. doi:10.1001/jamaoncol.2016.2667 - DOI - PubMed

Publication types